$0.43
0.00% day before yesterday
Nasdaq, Sep 06, 08:01 pm CET
ISIN
US19249J1097
Symbol
CWBR
Sector
Industry

CohBar Inc Stock price

$0.43
-0.07 14.00% 1M
-0.33 43.44% 6M
-0.31 41.89% YTD
-2.61 85.86% 1Y
-37.67 98.87% 3Y
-41.87 98.98% 5Y
-41.42 98.97% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
+0.00 0.00%
ISIN
US19249J1097
Symbol
CWBR
Sector
Industry

Key metrics

Market capitalization $1.25m
Enterprise Value $-11.06m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 1.39
P/B ratio (TTM) P/B ratio 0.13
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-13.13m
Free Cash Flow (TTM) Free Cash Flow $-7.95m
Cash position $12.31m
EPS (TTM) EPS $-4.37
Short interest 0.52%
Show more

Is CohBar Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

CohBar Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast CohBar Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast CohBar Inc:

Buy
100%

Financial data from CohBar Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '23
+/-
%
- -
-
100%
- Direct Costs 0.10 0.10
23% 23%
-
-0.10 -0.10
23% 23%
-
- Selling and Administrative Expenses 8.50 8.50
25% 25%
-
- Research and Development Expense 4.43 4.43
14% 14%
-
-13 -13
8% 8%
-
- Depreciation and Amortization 0.10 0.10
23% 23%
-
EBIT (Operating Income) EBIT -13 -13
8% 8%
-
Net Profit -13 -13
4% 4%
-

In millions USD.

Don't miss a Thing! We will send you all news about CohBar Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CohBar Inc Stock News

Neutral
Business Wire
10 months ago
MENLO PARK, Calif.--(BUSINESS WIRE)--On November 20, 2023, CohBar, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) of its determination pursuant to Nasdaq Listing Rule 5101 that, based upon the Staff's belief that the Company is a “public shell,” and that the continued listing of the Company's securities is no lo...
Neutral
PRNewsWire
more than one year ago
MILWAUKEE , May 24, 2023 /PRNewswire/ -- Ademi LLP is investigating CohBar (NASDAQ: CWBR) for possible breaches of fiduciary duty and other violations of law in its transaction with Morphogenesis, Inc.  Click here to learn how to join the action https://www.ademilaw.com/case/cohbar-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.
Positive
InvestorPlace
more than one year ago
CohBar (NASDAQ: CWBR ) stock is soaring higher on Tuesday after the company announced a planned merger with Morphogenesis . CohBar and Morphogenesis are planning for an all-stock merger that will see the two combine to create a new company named “TuHURA Biosciences, Inc.” This company will continue to trade its shares on The Nasdaq Capital Market.
More CohBar Inc News

Company Profile

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.

Head office United States
CEO Joseph Sarret
Employees 10
Founded 2007
Website www.cohbar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today